newsfilter
← Latest News
GlobeNewswire·

Ligand to Participate in September Investor Conferences

  • Ligand Pharmaceuticals (NASDAQ: LGND) announced its senior management team will attend three investor conferences in September 2026.
  • Management will participate in a fireside chat at the Wells Fargo Healthcare Conference 2026 in Boston on September 8, 2026, at 12:45 p.m. ET.
  • Management will attend a fireside chat at the Citi 2026 Biopharma Back to School Conference in New York on September 10, 2026, at 9:20 a.m. ET.
  • Management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14, 2026, at 10:00 a.m. ET.
  • Investors can arrange one-on-one meetings during these events by contacting their respective Wells Fargo, Citi, or H.C. Wainwright representatives.
  • Ligand operates as a royalty aggregator with economic interests in over 200 development & commercial-stage assets.
  • The company licenses its proprietary technologies, Captisol® & NITRICIL™, to support global drug development & formulation.
  • Investor inquiries should be directed to Melanie Herman at investors@ligand.com or (858) 550-7761.
  • Media inquiries should be directed to Kellie Walsh at media@ligand.com or (914) 315-6072.